Role of PCSK9 in breast cancer: a systematic review of its mechanistic pathways and clinical relevance
Introduction Breast cancer is a heterogeneous disease in which accurate classification based on biomarker expression is essential for effective therapeutic decision-making. Consequently, the identification of novel biomarkers remains a research priority. Proprotein convertase subtilisin/kexin type 9 (PCSK9), a key regu...